THE BUSINESS OF GENETIC INSTRUCTIONS APPLIED TO HUMANITY: “The mRNA vaccine platform for COVID-19 relies on the production of the coronavirus spike protein to elicit an immune response. Moderna, CureVac, Pfizer and BioNTech have all disclosed that the mRNA used in their vaccine candidates encodes a stabilized version of the spike protein that was developed by the NIH. A report by Public Citizen identified a pending patent application on this modified spike protein that was filed by the NIH19. The NIH also has four other provisional patent applications on a novel coronavirus vaccine as disclosed in a recent publication17.” ‘A network analysis of COVID-19 mRNA vaccine patents’ (May 2021) https://www.nature.com/articles/s41587-021-00912-9 Note: NIH plans are to parlay this network into a huge, ongoing Prototype Pathogen Preparedness program which will likely include risky gain-of-function (GOF) to produce prototype pathogens in order to design new genetic vaccines for all 26 viruses known to infect humans. This all dovetails with biodefense contracts.
Advocating for individual liberty and medical freedom for all Arkansans